Catalyst Wire Dossier Catalyst Wire Dossier

WAL2014 (Talsaclidine)

Talsaclidine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WAL2014 (Talsaclidine), covering 2014-10-15 to 2014-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers [Phase 1]

See pricing